Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Controlled Whole-body Vibration Training Reduces Risk Of Falls In People With Multiple Sclerosis: 1476 Board #129 June 2, 9: 00 AM - 10: 30 AM.
Magnetic Susceptibility from Quantitative Susceptibility Mapping Can Differentiate New Enhancing from Nonenhancing Multiple Sclerosis Lesions without Gadolinium Injection.
Walking impairs cognitive performance among people with multiple sclerosis but not controls.
Cognitive processess and cognitive reserve in multiple sclerosis.
Enantioselective analysis of 4-hydroxycyclophosphamide in human plasma with application to a clinical pharmacokinetic study.
Defining and scoring response to IFN-β in multiple sclerosis.
Atypical Rapidly Enlarging Orbital Schwannoma.
Blocking Glutamate Carboxypeptidase II Inhibits Glutamate Excitotoxicity and Regulates Immune Responses in Experimental Autoimmune Encephalomyelitis.
MTR recovery in brain lesions in the BECOME study of glatiramer acetate vs interferon β-1b.
Nogo receptor 1 is expressed in both primary cultured glial cells and neurons.
Stem cell treatment for multiple sclerosis.
MRI shows thickening and altered diffusion in the median and ulnar nerves in multifocal motor neuropathy.
Monoclonal Antibody Therapy for Neuromyelitis Optica Spectrum Disorder: Current and Future.
Assessment of brain metabolite correlates of AAV-mediated overexpression of human alpha-synuclein in cortical neurons by in vivo(1) H-MR spectroscopy at 9.4 T.
Strength of ERK1/2 MAPK Activation Determines Its Effect on Myelin and Axonal Integrity in the Adult CNS.
Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins.
Oral monomethylfumarate therapy ameliorates retinopathy in a humanized mouse model of sickle cell disease.
Anti Myelin-Associated-Glycoprotein Antibody Peripheral Neuropathy Response to Combination Chemoimmunotherapy With Bendamustine/Rituximab in a Patient With Biclonal IgM κ and IgM λ: Case Report and Review of the Literature.
Coding in Multiple Sclerosis and Other Demyelinating Diseases.
New Approaches to the Diagnosis, Clinical Course, and Goals of Therapy in Multiple Sclerosis and Related Disorders.
Is my MS patient failing treatment?
Bone metabolism and vitamin D status in patients with multiple sclerosis.
Responsiveness of the Multiple Sclerosis International Quality of Life questionnaire to disability change: a longitudinal study.
Accumulation of Extracellular Matrix in Advanced Lesions of Canine Distemper Demyelinating Encephalitis.
Do coping strategies mediate the association between Type D personality and quality of life among people with multiple sclerosis?

Pages